STUDY SUMMARY
Retroperitoneum Cancer Model: J000079689
NSG™ mice engrafted with passage 2 tumors for model J000079689
were randomly assigned to one of these treatment groups:
- 5% dextrose in water (vehicle control; 5 ml/kg; IV once per week for three times; N=8)
- Cisplatin (2 mg/kg; IV once per week for three times; N=8)
- Cyclophosphamide (40 mg/kg; IV once per week for three times; N=8)
- Docetaxel (10 mg/kg; IV once per week for three times; N=8)
- Topotecan (2 mg/kg; PO five times per week for three times )
Mice were monitored for tumor volume at least twice per week throughout the study period.
• Treatment groups
• Individual subjects / spider plot
• RECIST scores
• Waterfall plot
• TGI plot
• Protocols
Hide/show treatment groups
Hide/show treatment groups
Hide/show treatment groups